PDGFRB and Hepatic fibrosis: These results suggest that Metrnl inhibits HSCs activation by modulating the PDGFRβ signaling pathway, specifically through the regulation of PDGFB transcription and secretion from hepatocytes via EGR1 expression modulation, ultimately contributing to the amelioration of liver fibrosis.